Saturday 7 November 2026 Export NTLA’s income statement to Excel — free account

Intellia Therapeutics, Inc.

Intellia Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $67.7 million, up 16.9% from fiscal 2024.

Revenue: −48.0%
EPS: +1.09%
Free cash flow: −11.1%

Quarter to September 2026, against a year earlier

Insider buying

11.35 0.25 +2.25%

Follow NTLA

Alert me

Market cap: $1.6B
P/E: 0.0×
Fwd P/E: −3.4×
Dividend yield: —
F-score: 4/9
Altman Z: −1.93
Beneish M: −2.68
Dividend safety: n/a

Overview

	Sep '26 From the 10-Q filed 5 Nov	Jun '26	Mar '26	Dec '25	Older periods
ROE Full definition →	(62.60%)	(55.44%)	(56.34%)	(53.48%)	+8 more TTM periods Free account
Piotroski F-Score Full definition →	4	5	5	4
ROA Full definition →	(46.63%)	(45.55%)	(45.23%)	(40.60%)
ROIC Full definition →	(195.32%)	(91.28%)	(107.35%)	(124.43%)
Return on Tangible Assets Full definition →	(96.86%)	(86.29%)	(97.31%)	(93.48%)
Average Days of Receivables Full definition →	51.75	44.91	50.43	51.07
Free Cash Flow per Share Full definition →	(2.53)	(2.61)	(3.07)	(3.65)
Free Cash Flow Full definition →	(355.17)	(348.60)	(363.62)	(395.86)
Capital Expenditures Full definition →	—	(1.95)	(0.47)	(1.13)
Other line items
Cash ROIC Full definition →	(32.67%)	(29.91%)	(36.47%)	(35.30%)
Accounts Receivable Turnover Full definition →	5.70	6.37	6.73	7.53
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	634.05%	582.68%	546.47%	574.63%
Selling, General and Administrative Expense of Revenue Full definition →	287.19%	228.98%	190.09%	177.03%
Share Based Compensation of Revenue Full definition →	118.53%	114.10%	108.72%	118.54%
Operating CF/Net income Full definition →	0.83	0.87	0.92	0.96
Depreciation/Fixed assets Full definition →	0.00	1.01	1.01	0.90
Capex/Depreciation Full definition →	—	(0.13)	(0.03)	(0.07)
Revenue per Share Full definition →	0.38	0.45	0.56	0.62
Operating CF per Share Full definition →	(2.53)	(2.60)	(3.06)	(3.64)
Capex per Share Full definition →	0.00	(0.01)	0.00	(0.01)
Capex to Sales Full definition →	0.00	0.03	0.01	0.02

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly